Clinical Trial Update: Upfront Combination Pulmonary Arterial Hypertension Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on upfront combination therapy for pulmonary hypertension is reported, with the status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: University of Calgary | Conditions: Pulmonary Hypertension | Phase 4 | Status: UNKNOWN